UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.990

Sortiert nach

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers

Oncogene, 2016-01, Vol.35 (2), p.173-186

2016

Volltextzugriff (PDF)

Identifying immune signatures of sepsis to increase diagnostic accuracy in very preterm babies

Nature communications, 2024-01, Vol.15 (1), p.388-388, Article 388

2024

Volltextzugriff (PDF)

Multiplatform-based molecular subtypes of non-small-cell lung cancer

Oncogene, 2017-03, Vol.36 (10), p.1384-1393

2017

Volltextzugriff (PDF)

Mouse and human intestinal immunity: same ballpark, different players; different rules, same score

Mucosal immunology, 2011-03, Vol.4 (2), p.148-157

2011

Volltextzugriff (PDF)

Perinatal inflammation influences but does not arrest rapid immune development in preterm babies

Nature communications, 2020-03, Vol.11 (1), p.1284-1284, Article 1284

2020

Volltextzugriff (PDF)

57O Efficacy, safety and tolerability of MEDI4736 (durvalumab [D]), a human IgG1 anti-programmed cell death-ligand-1 (PD-L1) antibody, combined with gefitinib (G): A phase I expansion in TKI-naïve patients (pts) with EGFR mutant NSCLC

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S79-S79

2016

Volltextzugriff (PDF)

ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis

Oncogene, 2017-04, Vol.36 (14), p.1925-1938

2017

Volltextzugriff (PDF)

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of oncology, 2022-01, Vol.33 (1), p.42-56

2022

Volltextzugriff (PDF)

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Annals of oncology, 2017-01, Vol.28 (1), p.75-82

2017

Volltextzugriff (PDF)

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

Annals of oncology, 2017-01, Vol.28 (1), p.83-89

2017

Volltextzugriff (PDF)

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

Annals of oncology, 2024-02, Vol.35 (2), p.183-189

2024

Volltextzugriff (PDF)

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii738-viii738

2018

Volltextzugriff (PDF)

DNA damaging agents and immunotherapy in NSCLC: Is there a STING in the tale?

Annals of oncology, 2018-10, Vol.29, p.viii45-viii45

2018

Volltextzugriff (PDF)

Phase I study of gefitinib (G) + durvalumab (D) for locally advanced/metastatic non-small cell lung cancer (NSCLC) harbouring epidermal growth factor receptor (EGFR) sensitising mutations

Annals of oncology, 2019-04, Vol.30, p.ii31-ii32

2019

Volltextzugriff (PDF)

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Annals of oncology, 2018-04, Vol.29 (4), p.1072-1072

2018

Volltextzugriff (PDF)

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii680-viii680

2018

Volltextzugriff (PDF)

Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus

Nature, 2004-01, Vol.427 (6972), p.320-325

2004

Volltextzugriff (PDF)

Formation and Characterization of the Trimeric Form of the Fusion Protein of Semliki Forest Virus

Journal of Virology, 2000-09, Vol.74 (17), p.7772-7780

2000

Volltextzugriff (PDF)

The Fusion Peptide of Semliki Forest Virus Associates with Sterol-Rich Membrane Domains

Journal of Virology, 2002-04, Vol.76 (7), p.3267-3275

2002

Volltextzugriff (PDF)

ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block

Oncogene, 1996-11, Vol.13 (10), p.2225-2234

1996

Volltextzugriff (PDF)

Multistep Regulation of Membrane Insertion of the Fusion Peptide of Semliki Forest Virus

Journal of Virology, 2004-04, Vol.78 (7), p.3312-3318

2004

Volltextzugriff (PDF)

TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins

Nature communications, 2018-07, Vol.9 (1), p.2731-16, Article 2731

2018

Volltextzugriff (PDF)

Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia

Leukemia, 2008-04, Vol.22 (4), p.877-878

2008

Volltextzugriff (PDF)

Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1(T315I) and other mutants compared to direct sequencing of the ABL1 kinase domain

Leukemia, 2008-04, Vol.22 (4), p.885-888

2008

Volltextzugriff (PDF)

Lymphotoxin acts as an autocrine growth factor for Epstein‐Barr virus‐transformed B cells and differentiated Burkitt lymphoma cell lines

European journal of immunology, 1994-08, Vol.24 (8), p.1879-1885

1994

Volltextzugriff (PDF)

1 – 25 von 1.990

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.636)
Mit Volltextzugriff
(1.773)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.060)
Life Sciences & Biomedicine
(815)
Humans
(689)
Female
(409)
Male
(391)
Biological And Medical Sciences
(367)
Medical Sciences
(303)
Middle Aged
(239)
Adult
(237)
Physical Sciences
(184)
Aged
(180)
Animals
(179)
Physics
(163)
Cardiovascular System & Cardiology
(108)
Cardiac & Cardiovascular Systems
(92)
Surgery
(85)
Social Sciences
(80)
Adolescent
(79)
Fundamental And Applied Biological Sciences. Psychology
(77)
Technology
(74)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers

Identifying immune signatures of sepsis to increase diagnostic accuracy in very preterm babies

Multiplatform-based molecular subtypes of non-small-cell lung cancer

Mouse and human intestinal immunity: same ballpark, different players; different rules, same score

Perinatal inflammation influences but does not arrest rapid immune development in preterm babies

57O Efficacy, safety and tolerability of MEDI4736 (durvalumab [D]), a human IgG1 anti-programmed cell death-ligand-1 (PD-L1) antibody, combined with gefitinib (G): A phase I expansion in TKI-naïve patients (pts) with EGFR mutant NSCLC

ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)

DNA damaging agents and immunotherapy in NSCLC: Is there a STING in the tale?

Phase I study of gefitinib (G) + durvalumab (D) for locally advanced/metastatic non-small cell lung cancer (NSCLC) harbouring epidermal growth factor receptor (EGFR) sensitising mutations

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)

Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus

Formation and Characterization of the Trimeric Form of the Fusion Protein of Semliki Forest Virus

The Fusion Peptide of Semliki Forest Virus Associates with Sterol-Rich Membrane Domains

ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block

Multistep Regulation of Membrane Insertion of the Fusion Peptide of Semliki Forest Virus

TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins

Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia

Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1(T315I) and other mutants compared to direct sequencing of the ABL1 kinase domain

Lymphotoxin acts as an autocrine growth factor for Epstein‐Barr virus‐transformed B cells and differentiated Burkitt lymphoma cell lines

Suchergebnisse filtern